DMK Pharmaceuticals Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 3/19/2023)
| Balance Sheet | Total Assets | 10,930,800.00 | ROE | – |
| Balance Sheet | Total Equity | -808,068.00 | ROA | – |
| Cashflow | Capital Expenditures | -680,417.00 | P/FCF | – |
| Cashflow | Free Cash Flow | -26,580,920.00 | – | – |
| Cashflow | Operating Cash Flow | -9,375,360.00 | P/CF | – |
| Income | Earnings per Share (diluted) | -12.60 | Div. Yield | – |
| Income | Net Income | -22,232,600.00 | P/E | – |
| Income | Shares Outstanding | 2,140,730.00 | P/B | – |
| Income | Total Revenue | 3,619,690.00 | P/S | – |
Ratios calculated on: –
Company Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's specialty pharmaceutical product candidates comprise Symjepi (epinephrine) Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis. It also offers dry powder inhaler products consisting of fluticasone (APC-4000) for the treatment of asthma; beclomethasone (APC-1000), a metered dose inhaler product for the asthma; Tadalafil (APC-8000) for the treatment of erectile dysfunction; and naloxone injection product candidates (APC-6000) for the treatment of opioid overdose. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and certain veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation is headquartered in San Diego, California.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.adamispharmaceuticals.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more